|
CALGARY, ALBERTA--(Marketwired - March 25, 2014) - Supreme Pharmaceuticals Inc. (the "Company") (TSX VENTURE:SL)(OTCBB:SPRWF) is pleased to announce that the Company has signed a conditional agreement with an arms-length South Okanagan-based company, whereby the Company has the option to purchase its producing medical marijuana business until March 23, 2015 for the sum of $1,000,000, payable in cash and shares, subject to regulatory approval. The Company is currently in a 10-business day due diligence period and if satisfied, Supreme will, subject to prior approval of the TSXV, make a $100,000 option payment. |
